Appendix 3Y - Helen Wiseman
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity:
Elixinol Wellness Limited
ABN:
621 479 794
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Helen Wiseman
Date of last notice
2 September 2023
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
N/A
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
30 September 2023
No. of securities held prior to change
1,599,577 Fully paid Ordinary Shares
1,043,424 Performance Share Rights
2,291,667 Director Fee rights
1,319,445 Unlisted Options
Class
1) Performance Share Rights
2) Director Fee rights
Number acquired
1) Nil
2) Nil
+ See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Number disposed
1)
2)
Value/Consideration
Nil financial consideration – Performance
Share Rights and Director Fee Rights
lapsed on resignation as director.
1,599,577 Fully paid Ordinary Shares
1,319,445 Unlisted Options
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buyback
1,043,424
2,291,667
Lapse of Performance Share Rights and
Director Fee Rights
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was N/A
this provided?
+ See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3
Share your feedback
Discover